BACKGROUND: Human adenoviruses (HAdVs) are known causes of respiratory illness outbreaks in congregate settings, but cases and clusters are less well described from community settings in the United States. During December 2016-February 2017, the New Jersey Department of Health received reports of HAdV infections from 3 sources in 3 adjacent counties. We investigated to characterize the epidemiologic, laboratory, and clinical features of this HAdV outbreak. METHODS: A case was defined as a New Jersey resident with acute respiratory illness during December 1, 2016-March 31, 2017 with laboratory identification of HAdV genome type 7d (HAdV-7d). Human adenovirus was detected by real-time and conventional polymerase chain reaction and molecular typed by partial hexon capsid protein gene sequencing. The HAdV genome type was identified by whole genome sequencing analysis. Available medical, public health, and surveillance records were reviewed. RESULTS: We identified 12 cases, including 3 treatment facility patients, 7 college students, and 2 cases at a tertiary-care hospital. Four cases died; all had underlying comorbidities. Nine HAdV-7d whole genome sequences obtained from all 3 sites were nearly identical. CONCLUSIONS: Transmission of HAdV-7d occurred in community and congregate settings across 3 counties and resulted in severe morbidity and mortality in some cases with underlying comorbidities. Clinicians and local and state health departments should consider HAdV in patients with severe respiratory infection.
BACKGROUND: Human adenoviruses (HAdVs) are known causes of respiratory illness outbreaks in congregate settings, but cases and clusters are less well described from community settings in the United States. During December 2016-February 2017, the New Jersey Department of Health received reports of HAdV infections from 3 sources in 3 adjacent counties. We investigated to characterize the epidemiologic, laboratory, and clinical features of this HAdV outbreak. METHODS: A case was defined as a New Jersey resident with acute respiratory illness during December 1, 2016-March 31, 2017 with laboratory identification of HAdV genome type 7d (HAdV-7d). Human adenovirus was detected by real-time and conventional polymerase chain reaction and molecular typed by partial hexon capsid protein gene sequencing. The HAdV genome type was identified by whole genome sequencing analysis. Available medical, public health, and surveillance records were reviewed. RESULTS: We identified 12 cases, including 3 treatment facility patients, 7 college students, and 2 cases at a tertiary-care hospital. Four cases died; all had underlying comorbidities. Nine HAdV-7d whole genome sequences obtained from all 3 sites were nearly identical. CONCLUSIONS: Transmission of HAdV-7d occurred in community and congregate settings across 3 counties and resulted in severe morbidity and mortality in some cases with underlying comorbidities. Clinicians and local and state health departments should consider HAdV in patients with severe respiratory infection.
Entities:
Keywords:
acute respiratory disease; human adenovirus; outbreak; respiratory virus
Authors: Margaret A K Ryan; Gregory C Gray; Besa Smith; Jamie A McKeehan; Anthony W Hawksworth; Marietta D Malasig Journal: Clin Infect Dis Date: 2002-01-16 Impact factor: 9.079
Authors: S I Gerber; D D Erdman; S L Pur; P S Diaz; J Segreti; A E Kajon; R P Belkengren; R C Jones Journal: Clin Infect Dis Date: 2001-02-20 Impact factor: 9.079
Authors: Paul F Lewis; Mark A Schmidt; Xiaoyan Lu; Dean D Erdman; Mary Campbell; Ann Thomas; Paul R Cieslak; La Donna Grenz; Laura Tsaknardis; Curt Gleaves; Brian Kendall; David Gilbert Journal: J Infect Dis Date: 2009-05-15 Impact factor: 5.226
Authors: Kevin L Russell; Anthony W Hawksworth; Margaret A K Ryan; Jennifer Strickler; Marina Irvine; Christian J Hansen; Gregory C Gray; Joel C Gaydos Journal: Vaccine Date: 2006-01-24 Impact factor: 3.641
Authors: Gregory C Gray; Troy McCarthy; Mark G Lebeck; David P Schnurr; Kevin L Russell; Adriana E Kajon; Marie L Landry; Diane S Leland; Gregory A Storch; Christine C Ginocchio; Christine C Robinson; Gail J Demmler; Michael A Saubolle; Sue C Kehl; Rangaraj Selvarangan; Melissa B Miller; James D Chappell; Danielle M Zerr; Deanna L Kiska; Diane C Halstead; Ana W Capuano; Sharon F Setterquist; Margaret L Chorazy; Jeffrey D Dawson; Dean D Erdman Journal: Clin Infect Dis Date: 2007-09-27 Impact factor: 9.079
Authors: Lyn James; Michael O Vernon; Roderick C Jones; Anita Stewart; Xiaoyan Lu; Lowell M Zollar; Maria Chudoba; Matthew Westercamp; Grace Alcasid; Liane Duffee-Kerr; Linda Wood; Sue Boonlayangoor; Cindy Bethel; Kathleen Ritger; Craig Conover; Dean D Erdman; Susan I Gerber Journal: Clin Infect Dis Date: 2007-06-28 Impact factor: 9.079
Authors: Jeannette Guarner; Julu Bhatnagar; Wun-Ju Shieh; Kurt B Nolte; Dennis Klein; Michelle S Gookin; Silvia Peñaranda; M Steven Oberste; Tara Jones; Chalanda Smith; Mark A Pallansch; Sherif R Zaki Journal: Hum Pathol Date: 2007-06-28 Impact factor: 3.466
Authors: Jennifer Ann Marie Calder; Dean D Erdman; Joel Ackelsberg; Stephen William Cato; Vicki-Jo Deutsch; Anthony John Lechich; Barbara Susan Schofield Journal: Emerg Infect Dis Date: 2004-01 Impact factor: 6.883
Authors: Alicia M Alcamo; Michael S Wolf; Lauren J Alessi; Hey J Chong; Michael Green; John V Williams; Dennis W Simon Journal: Pediatrics Date: 2019-12-11 Impact factor: 7.124
Authors: Nelsa Matienzo; Mariam M Youssef; Devon Comito; Benjamin Lane; Chanel Ligon; Haruka Morita; Arianna Winchester; Mary E Decker; Peter Dayan; Bo Shopsin; Jeffrey Shaman Journal: Influenza Other Respir Viruses Date: 2020-07-30 Impact factor: 4.380